RxDoctor Payments Data

Cara O'Reilly, NP

Nurse Practitioner · Middletown, DENPI 1770145120

Payments from drug & device makers

$480in general payments, 2019–2025

Across 26 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$104
  • Astellas Pharma US Inc$52
  • AstraZeneca$49
  • Lilly USA, LLC$37
  • Merck$33
  • Abbott$33
  • plus $171 from 9 others

What the payments were for

  • Food & beverage$480100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$480 in reported general payments places this provider in the 65th percentile of 487 nurse practitioner providers in Delaware.

See all nurse practitioner providers in Delaware

Medicare billing

Part B allowed, 2024
$2,204
Medicare patients
44
Services billed
47

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate18$260

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Middletown

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →